Literature DB >> 19737696

Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition.

Jun Tanigawa1, Peter Barlis, Carlo Di Mario.   

Abstract

Stent expansion, apposition and symmetry were the three criteria of intravascular ultrasound (IVUS) guided optimal stent deployment in the bare metal stent era1, with at least the criterion of stent expansion maintaining its clinical relevance in the drug-eluting stent (DES) era2. Two prospective studies showed that stent malapposition immediately following DES implantation was not associated with increased adverse clinical events3,4. Thus, initial concerns that immediate stent malapposition would affect drug delivery to the vessel wall and lead to DES failure appeared to be unfounded. Coronary IVUS, however, formerly the gold standard for assessing stent strut apposition, is imprecise in the detection of stent malapposition observed in around 7% of lesions3,4, a figure which is probably grossly underestimated. This is due to the limited axial and lateral resolution of the ultrasound waves (100-150 microm) and the constant presence of artefacts around stent struts (side-lobes, shadowing). Optical coherence tomography (OCT) uses infrared light with the advantage of greater resolution (10-15 microm) and less strut induced artefacts compared with IVUS5,6. Unlike the first OCT prototypes used by Jang et al5,6, new commercial systems (LightLab Imaging Inc., Westford, MA, USA) can acquire contiguous images with a motorised pullback system as used with IVUS7. Still, OCT has some disadvantages including a more complex process of image acquisition that requires transient proximal flow occlusion with a balloon. Since there is definite learning curve to achieve optimal image quality, this article will focus on methods and techniques to attain optimal assessment of stent strut apposition, using the current OCT system.

Entities:  

Year:  2007        PMID: 19737696

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  32 in total

1.  Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.

Authors:  Byeong-Keuk Kim; Dong-Ho Shin; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-25       Impact factor: 2.357

2.  Dual-element needle transducer for intravascular ultrasound imaging.

Authors:  Sangpil Yoon; Min Gon Kim; Jay A Williams; Changhan Yoon; Bong Jin Kang; Nestor Cabrera-Munoz; K Kirk Shung; Hyung Ham Kim
Journal:  J Med Imaging (Bellingham)       Date:  2015-04-13

3.  Comparison of the vessel healing process after everolimus-eluting stent and bare metal stent implantations in patients with ST-elevation myocardial infarction.

Authors:  Hideki Yano; Shigeo Horinaka; Manami Watahik; Tomoko Watanabe; Toshihiko Ishimitsu
Journal:  Heart Vessels       Date:  2018-11-03       Impact factor: 2.037

4.  Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results.

Authors:  Tae-Hoon Kim; Jung-Sun Kim; Byoung-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-27       Impact factor: 2.357

5.  Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.

Authors:  Jung-Sun Kim; Jin-Sun Kim; Dong-Ho Shin; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2011-08-21       Impact factor: 2.357

Review 6.  Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights.

Authors:  Daniel S Ong; Ik-Kyung Jang
Journal:  Nat Rev Cardiol       Date:  2015-03-17       Impact factor: 32.419

7.  Early vascular responses after everolimus-eluting stent implantation assessed by serial observations of intracoronary optical coherence tomography.

Authors:  Hideki Yano; Shigeo Horinaka; Mayuko Ishikawa; Toshihiko Ishimitsu
Journal:  Heart Vessels       Date:  2017-02-14       Impact factor: 2.037

8.  A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model.

Authors:  Li Shen; Yizhe Wu; Lei Ge; Yaojun Zhang; Qibing Wang; Juying Qian; Zhifen Qiu; Junbo Ge
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-21       Impact factor: 2.357

9.  The initial extent of malapposition in ST-elevation myocardial infarction treated with drug-eluting stent: the usefulness of optical coherence tomography.

Authors:  Ung Kim; Jung-Sun Kim; Jin-Sun Kim; Jung-Myung Lee; Jung-Woo Son; Jaedeok Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

10.  Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents.

Authors:  J-S Kim; I-K Jang; J-S Kim; T H Kim; M Takano; T Kume; N W Hur; Y-G Ko; D Choi; M-K Hong; Y Jang
Journal:  Heart       Date:  2009-06-16       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.